{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T06:38:52Z","timestamp":1721371132779},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1177\/1933719116648219","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T02:24:23Z","timestamp":1463019863000},"page":"1559-1564","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Serum YKL-40 Level Positively Correlates With Uterine Leiomyomas"],"prefix":"10.1007","volume":"23","author":[{"given":"Wenping","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"issue":"6553","key":"23111559_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.293.6543.359","volume":"293","author":"RK Ross","year":"1986","unstructured":"Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed). 1986;293(6553):359\u2013362.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"23111559_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","volume":"94","author":"SF Cramer","year":"1990","unstructured":"Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435\u2013438.","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"23111559_CR3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/humrep\/16.8.1726","volume":"16","author":"JB Dubuisson","year":"2001","unstructured":"Dubuisson JB, Fauconnier A, Fourchotte V, Babaki-Fard K, Coste J, Chapron C. Laparoscopic myomectomy: predicting the risk of conversion to an open procedure. Hum Reprod. 2001;16(8):1726\u20131731.","journal-title":"Hum Reprod"},{"issue":"4","key":"23111559_CR4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/humrep\/den467","volume":"24","author":"MC Lafay Pillet","year":"2009","unstructured":"Lafay Pillet MC, Leonard F, Chopin N, et al. Incidence and risk factors of bladder injuries during laparoscopic hysterectomy indicated for benign uterine pathologies: a 14.5 years experience in a continuous series of 1501 procedures. Hum Reprod. 2009;24(4):842\u2013849.","journal-title":"Hum Reprod"},{"issue":"2","key":"23111559_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2011.04.021","volume":"122","author":"JY Park","year":"2011","unstructured":"Park JY, Park SK, Kim DY, et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol. 2011;122(2):255\u2013259.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"23111559_CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/IGC.0b013e31819a1f8f","volume":"19","author":"T Perri","year":"2009","unstructured":"Perri T, Korach J, Sadetzki S, et al. Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer. 2009;19(2):257\u2013260.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"23111559_CR7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bpobgyn.2011.08.002","volume":"26","author":"T Van den Bosch","year":"2012","unstructured":"Van den Bosch T, Coosemans A, Morina M, Timmerman D, Amant F. Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):257\u2013266.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"23111559_CR8","first-page":"412","volume":"30","author":"N Yilmaz","year":"2009","unstructured":"Yilmaz N, Sahin I, Kilic S, Ozgu E, Gungor T, Bilge U. Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population. Eur J Gynaecol Oncol. 2009;30(4):412\u2013414.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"23111559_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0030-1251476","volume":"28","author":"N Chegini","year":"2010","unstructured":"Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28(3):180\u2013203.","journal-title":"Semin Reprod Med"},{"issue":"2","key":"23111559_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.mehy.2012.04.046","volume":"79","author":"G Wegienka","year":"2012","unstructured":"Wegienka G. Are uterine leiomyoma a consequence of a chronically inflammatory immune system? Med Hypotheses. 2012;79(2):226\u2013231.","journal-title":"Med Hypotheses"},{"issue":"1","key":"23111559_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2005.12.001","volume":"33","author":"EE Marsh","year":"2006","unstructured":"Marsh EE, Bulun SE. Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am. 2006;33(1):59\u201367.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"11","key":"23111559_CR12","first-page":"4092","volume":"83","author":"K Englund","year":"1998","unstructured":"Englund K, Blanck A, Gustavsson I, et al. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. J Clin Endocrinol Metab. 1998;83(11):4092\u20134096.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"23111559_CR13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/humupd\/dmr031","volume":"17","author":"P Ciarmela","year":"2011","unstructured":"Ciarmela P, Islam MS, Reis FM, et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 2011;17(6):772\u2013790.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"23111559_CR14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","volume":"100","author":"MS Islam","year":"2013","unstructured":"Islam MS, Protic O, Stortoni P, et al. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Fertil Steril. 2013;100(1):178\u2013193.","journal-title":"Fertil Steril"},{"issue":"2","key":"23111559_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0301-2115(03)00244-6","volume":"111","author":"N Inagaki","year":"2003","unstructured":"Inagaki N, Ung L, Otani T, Wilkinson D, Lopata A. Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol. 2003;111(2):197\u2013203.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"23111559_CR16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","volume":"13","author":"LJ McCawley","year":"2001","unstructured":"McCawley LJ, Matrisian LM. Matrix metalloproteinases: they\u2019re not just for matrix anymore! Curr Opin Cell Biol. 2001;13(5):534\u2013540.","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"23111559_CR17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1067\/mob.2001.111160","volume":"184","author":"LM Senturk","year":"2001","unstructured":"Senturk LM, Sozen I, Gutierrez L, Arici A. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma. Am J Obstet Gynecol. 2001;184(4):559\u2013566.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"23111559_CR18","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/humrep\/det238","volume":"28","author":"P Santulli","year":"2013","unstructured":"Santulli P, Even M, Chouzenoux S, et al. Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden. Hum Reprod. 2013;28(8):2126\u20132133.","journal-title":"Hum Reprod"},{"issue":"2","key":"23111559_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/geno.1997.4778","volume":"43","author":"M Rehli","year":"1997","unstructured":"Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. 1997;43(2):221\u2013225.","journal-title":"Genomics"},{"issue":"7","key":"23111559_CR20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2217\/fon.09.66","volume":"5","author":"JS Johansen","year":"2009","unstructured":"Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol. 2009;5(7):1065\u20131082.","journal-title":"Future Oncol"},{"issue":"6","key":"23111559_CR21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00011-006-0076-y","volume":"55","author":"CN Rathcke","year":"2006","unstructured":"Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res. 2006;55(6):221\u2013227.","journal-title":"Inflamm Res"},{"key":"23111559_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2840-8-61","volume":"8","author":"CN Rathcke","year":"2009","unstructured":"Rathcke CN, Vestergaard H. YKL-40\u2014an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol. 2009;8:61.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"23111559_CR23","first-page":"287","volume":"4","author":"G Hamilton","year":"2015","unstructured":"Hamilton G, Rath B, Burghuber O. Chitinase-3-like-1\/YKL-40 as marker of circulating tumor cells. Transl Lung Cancer Res. 2015;4(3):287\u2013291.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"23111559_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/147323000903700102","volume":"37","author":"K Huang","year":"2009","unstructured":"Huang K, Wu LD. YKL-40: a potential biomarker for osteoarthritis. J Int Med Res. 2009;37(1):18\u201324.","journal-title":"J Int Med Res"},{"key":"23111559_CR25","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar1471","volume":"7","author":"H Lorenz","year":"2005","unstructured":"Lorenz H, Wenz W, Ivancic M, Steck E, Richter W. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther. 2005;7:R156\u2013R165.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"23111559_CR26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/bmm.10.58","volume":"4","author":"AB Mathiasen","year":"2010","unstructured":"Mathiasen AB, Henningsen KM, Harutyunyan MJ, Mygind ND, Kastrup J. YKL-40: a new biomarker in cardiovascular disease? Biomark Med. 2010;4(4):591\u2013600.","journal-title":"Biomark Med"},{"key":"23111559_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","volume":"7","author":"D Bonneh-Barkay","year":"2010","unstructured":"Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA. In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation. 2010;7:34.","journal-title":"J Neuroinflammation"},{"key":"23111559_CR28","doi-asserted-by":"crossref","first-page":"22421","DOI":"10.3390\/ijms151222421","volume":"15","author":"S Wu","year":"2014","unstructured":"Wu S, Hsu LA, Cheng ST, et al. Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease. Int J Mol Sci. 2014;15:22421\u201322437.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"23111559_CR29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/neu.2010.1310","volume":"27","author":"D Bonneh-Barkay","year":"2010","unstructured":"Bonneh-Barkay D, Zagadailov P, Zou H, et al. YKL-40 expression in traumatic brain injury: an initial analysis. J Neurotrauma. 2010;27(7):1215\u20131223.","journal-title":"J Neurotrauma"},{"issue":"5","key":"23111559_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/00365540110080233","volume":"34","author":"G Kronborg","year":"2002","unstructured":"Kronborg G, Ostergaard C, Weis N, et al. Serum level of YKL-40 is elevated in patients with ***Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis. 2002;34(5):323\u2013326.","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"23111559_CR31","doi-asserted-by":"crossref","first-page":"e50826","DOI":"10.1371\/journal.pone.0050826","volume":"7","author":"NJ Sarma","year":"2012","unstructured":"Sarma NJ, Tiriveedhi V, Subramanian V, et al. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One. 2012;7(11):e50826.","journal-title":"PLoS One"},{"issue":"2suppl1","key":"23111559_CR32","first-page":"130","volume":"29","author":"M Filippelli","year":"2015","unstructured":"Filippelli M, Cuppari C, Giacchi V, et al. Serum and Bal Ykl-40 levels in different inflammatory lung diseases: an update. J Biol Regul Homeost Agents. 2015;29(2 suppl 1):130\u2013136.","journal-title":"J Biol Regul Homeost Agents"},{"key":"23111559_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2466-13-77","volume":"13","author":"DB Holmgaard","year":"2013","unstructured":"Holmgaard DB, Mygind LH, Titlestad IL, et al. Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2013;13:77.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"23111559_CR34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1164\/rccm.201405-0796OC","volume":"191","author":"F Ahangari","year":"2015","unstructured":"Ahangari F, Sood A, Ma B, et al. Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation. Am J Respir Crit Care Med. 2015;191(7):746\u2013757.","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"23111559_CR35","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa073600","volume":"357","author":"GL Chupp","year":"2007","unstructured":"Chupp GL, Lee CG, Jarjour N, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med. 2007;357(20):2016\u20132027.","journal-title":"N Engl J Med"},{"issue":"2suppl1","key":"23111559_CR36","first-page":"114","volume":"29","author":"S Leonardi","year":"2015","unstructured":"Leonardi S, Filippelli M, Lanzafame A, et al. Serum Ykl-40 in Children with Asthma. J Biol Regul Homeost Agents. 2015;29(2 suppl 1):114\u2013119.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"8","key":"23111559_CR37","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.fertnstert.2010.12.051","volume":"95","author":"L Benaglia","year":"2011","unstructured":"Benaglia L, Somigliana E, de Benedictis S, et al. Hyperstimulation during IVF cycles does not modify dimensions of small subserosal and intramural leiomyomas. Fertil Steril. 2011;95(8):2489\u20132491.","journal-title":"Fertil Steril"},{"issue":"4","key":"23111559_CR38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/humrep\/der015","volume":"26","author":"E Somigliana","year":"2011","unstructured":"Somigliana E, De Benedictis S, Vercellini P, et al. Fibroids not encroaching the endometrial cavity and IVF success rate: a prospective study. Hum Reprod. 2011;26(4):834\u2013839.","journal-title":"Hum Reprod"},{"key":"23111559_CR39","volume-title":"Cell Tissue Res","author":"O Protic","year":"2015","unstructured":"Protic O, Toti P, Islam MS, et al. Possible involvement of inflammatory\/reparative processes in the development of uterine fibroids [published online November 27, 2015]. Cell Tissue Res. 2015."},{"issue":"5","key":"23111559_CR40","first-page":"2275","volume":"86","author":"O Kurachi","year":"2001","unstructured":"Kurachi O, Matsuo H, Samoto T, Maruo T. Tumor necrosis factor-alpha expression in human uterine leiomyoma and its down-regulation by progesterone. J Clin Endocrinol Metab. 2001;86(5):2275\u20132280.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"23111559_CR41","first-page":"295","volume":"29","author":"KV Litovkin","year":"2007","unstructured":"Litovkin KV, Domenyuk VP, Bubnov VV, Zaporozhan VN. Interleukin-6 -174G\/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study. Exp Oncol. 2007;29(4):295\u2013298.","journal-title":"Exp Oncol"},{"issue":"3","key":"23111559_CR42","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/en.2004-1377","volume":"146","author":"X Luo","year":"2005","unstructured":"Luo X, Ding L, Xu J, et al. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology. 2005;146(3):1097\u20131118.","journal-title":"Endocrinology"},{"issue":"1","key":"23111559_CR43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ogc.2005.12.005","volume":"33","author":"I Sozen","year":"2006","unstructured":"Sozen I, Arici A. Cellular biology of myomas: interaction of sex steroids with cytokines and growth factors. Obstet Gynecol Clin North Am. 2006;33(1):41\u201358.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"23111559_CR44","first-page":"30","volume":"5","author":"P Bischof","year":"2001","unstructured":"Bischof P. Endocrine, paracrine and autocrine regulation of trophoblastic metalloproteinases. Early Pregnancy. 2001;5(1):30\u201331.","journal-title":"Early Pregnancy"},{"issue":"1","key":"23111559_CR45","first-page":"4","volume":"17","author":"JP Bastard","year":"2006","unstructured":"Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4\u201312.","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"23111559_CR46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10517-008-0038-1","volume":"145","author":"KA Syssoev","year":"2008","unstructured":"Syssoev KA, Kulagina NV, Chukhlovin AB, Morozova EB, Totolian AA. Expression of mRNA for chemokines and chemokine receptors in tissues of the myometrium and uterine leiomyoma. Bull Exp Biol Med. 2008;145(1):84\u201389.","journal-title":"Bull Exp Biol Med"},{"issue":"1","key":"23111559_CR47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1071-5576(02)00191-0","volume":"10","author":"K Cesen-Cummings","year":"2003","unstructured":"Cesen-Cummings K, Houston KD, Copland JA, Moorman VJ, Walker CL, Davis BJ. Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling. J Soc Gynecol Investig. 2003;10(1):11\u201320.","journal-title":"J Soc Gynecol Investig"},{"issue":"6","key":"23111559_CR48","first-page":"2226","volume":"84","author":"O Khorram","year":"1999","unstructured":"Khorram O, Garthwaite M, Magness RR. Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women. J Clin Endocrinol Metab. 1999;84(6):2226\u20132232.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"23111559_CR49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jbmr.5650070506","volume":"7","author":"JS Johansen","year":"1992","unstructured":"Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res. 1992;7(5):501\u2013512.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"23111559_CR50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3892\/or.2014.3195","volume":"32","author":"Y Akiyama","year":"2014","unstructured":"Akiyama Y, Ashizawa T, Komiyama M, et al. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line. Oncol Rep. 2014;32(1):159\u2013166.","journal-title":"Oncol Rep"},{"issue":"3","key":"23111559_CR51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2011.04.007","volume":"140","author":"CC Chen","year":"2011","unstructured":"Chen CC, Llado V, Eurich K, Tran HT, Mizoguchi E. Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1\/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clin Immunol. 2011;140(3):268\u2013275.","journal-title":"Clin Immunol"},{"issue":"1","key":"23111559_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.urolonc.2007.07.020","volume":"26","author":"M Kucur","year":"2008","unstructured":"Kucur M, Isman FK, Balci C, et al. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol. 2008;26(1):47\u201352.","journal-title":"Urol Oncol"},{"issue":"12","key":"23111559_CR53","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1590\/S0100-879X2010007500133","volume":"43","author":"L Zou","year":"2010","unstructured":"Zou L, He X, Zhang JW. The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer. Braz J Med Biol Res. 2010;43(12):1232\u20131238.","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"23111559_CR54","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/1535-7163.MCT-10-0868","volume":"10","author":"M Faibish","year":"2011","unstructured":"Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther. 2011;10(5):742\u2013751.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"23111559_CR55","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.urolonc.2014.02.004","volume":"32","author":"S Tschirdewahn","year":"2014","unstructured":"Tschirdewahn S, Reis H, Niedworok C, et al. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urol Oncol. 2014;32(5):663\u2013669.","journal-title":"Urol Oncol"},{"issue":"22","key":"23111559_CR56","first-page":"354","volume":"3","author":"J Yan","year":"2015","unstructured":"Yan J, Shen P, Zheng J, Liu M. Clinical correlation between serum YKL-40 protein level and recurrence of non-muscle invasive bladder cancer. Ann Transl Med. 2015;3(22):354.","journal-title":"Ann Transl Med"},{"issue":"4","key":"23111559_CR57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.12891\/ceog1882.2015","volume":"42","author":"UM Ural","year":"2015","unstructured":"Ural UM, Tekin YB, Cure M, \u015eahin FK. Serum YKL-40 levels as a novel marker of inflammation in patients with endometriosis. Clin Exp Obstet Gynecol. 2015;42(4):495\u2013497.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"23111559_CR58","volume-title":"J Cyst Fibros","author":"S Leonardi","year":"2016","unstructured":"Leonardi S, Parisi GF, Capizzi A, et al. YKL-40 as marker of severe lung disease in cystic fibrosis patients [published online January 8, 2016]. J Cyst Fibros. 2016."},{"issue":"9","key":"23111559_CR59","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3109\/10428194.2015.1004168","volume":"56","author":"AK Mylin","year":"2015","unstructured":"Mylin AK, Abildgaard N, Johansen JS, et al. Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma. Leuk Lymphoma. 2015;56(9):2650\u20132659.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"23111559_CR60","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-2265.2012.04437.x","volume":"77","author":"C Celik","year":"2012","unstructured":"Celik C, Abali R, Guzel S, Bastu E, Kucukyalcin V, Yilmaz M. Elevated circulating levels of YKL-40 are a marker of abnormal glucose tolerance in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77(6):893\u2013897.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116648219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719116648219","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719116648219\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719116648219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116648219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:51:59Z","timestamp":1656813119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719116648219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["23111559"],"URL":"https:\/\/doi.org\/10.1177\/1933719116648219","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"1 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}